Expanding Diabetes Business Supports ABT Stock, FX Issues Stay
Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose ...
Yahoo Finance25d
Reasons to Retain ABT Stock in Your Portfolio Now
In the fourth quarter of 2024, Core Laboratory Diagnostics recorded growth of 4%, driven ... of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre.
Nasdaq3d
Expanding Diabetes Business Supports ABT Stock, FX Issues Stay
Core Laboratory Diagnostics’ growth of 4% was driven by continued ... sales of its flagship, sensor-based continuous glucose monitoring system, FreeStyle Libre. In a relatively short span ...
drugdeliverybusiness4d
Medtronic seeks to expand MiniMed 780G label to type 2 diabetes, submits new CGM to FDA
Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...
Senseonics Completes CE Mark Submission For Eversense 365, World’S Longest-Lasting Continuous Glucose Monitor
The Eversense 365 CE Mark submission was prepared in compliance with the EU Medical Device Regulation (MDR) and, upon approval, would enable the commercialization of Eversense 365 in European Union ...
securities7d
A Breakthrough in Medical Monitoring: Next-Gen Medical Stabilization with Nanoparticle-Based Wearable Biosensors
Against the backdrop of aging, chronic diseases, and a growing population, the healthcare system is going through a vital transformation. Healthcare is simply becoming increasingly individual-centric.
pharmaphorum4d
Real-time Abbott glucose monitor available to NHS after UK launch
The FreeStyle Libre 3 system consists of the sensor around the size of a £1 coin that is worn on the upper arm and an app which can be used by users to record their real-time glucose levels and ...